Get started
Author

Asmaa Gohar

Observed names: A.M.I.H. gohar, Gohar, Asmaa
ORCID: 0009-0003-7911-8131
Observed ORCID: 0009-0003-7911-8131
OpenAlex ID: A5038278821
Monoclonal antibodies: From magic bullet to precision weapon
2024 · Hassan Aboul-Ella, Asmaa Gohar, et al. · Molecular Biomedicine · 66
Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Asmaa Gohar, Nourtan F. Abdeltawab, et al. · BMC Research Notes · 32
PDF
Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2/HO-1, PCSK9/HMGB1/NF-ᴋB/NLRP3 and Fractalkine/CX3CR1 hubs
2024 · Noha F. Hassan, Mona R. El-Ansary, et al. · Biomedicine & Pharmacotherapy · 28
Heat Shock Proteins: Central Players in Oncological and Immuno-Oncological Tracks
2022 · Rana A. Youness, Asmaa Gohar, et al. · Advances in experimental medicine and biology · 23
Combination therapy between prophylactic and therapeutic human papillomavirus (HPV) vaccines with special emphasis on implementation of nanotechnology
2022 · Asmaa Gohar, Aya A. Ali, et al. · Microbial Pathogenesis · 9
Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries
2019 · Asmaa Gohar, Nourtan F. Abdeltawab, et al. · Papillomavirus Research · 4
PDF
Bacillus-based probiotics ameliorate bleomycin-induced pulmonary fibrosis in rats: coupling intestinal barrier reinforcement to the modulation of M2 macrophage polarization/TGF-β/p38MAPK and inflammasome-driven pyroptosis
2026 · Noha F. Hassan, Samah G. Ahmed, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology
Cold and hot tumors: immunological determinants, cancer-immunity cycle dysregulation, and nanotechnology-driven therapeutic approaches
2026 · Mohammed S. Teiama, Asmaa Gohar, et al. · Molecular Biomedicine
PDF
Development of Safe, Effective and Immunogenic Vaccine Candidate for Diarrheagenic Escherichia coli Main Pathotypes in Mouse Model
2016 · A.M.I.H. gohar, N.F. Abdeltawab, et al. · International Journal of Infectious Diseases
PDF
MOESM5 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
MOESM6 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
MOESM3 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
MOESM7 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
MOESM1 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
MOESM4 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
MOESM2 of Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
2016 · Gohar, Asmaa, Abdeltawab, Nourtan, et al. · Figshare
Works count: 24
Citation count: 162
H-index: 5
I10-index: 4
Year
Topic
Type